DNA methylation and transcriptome signatures of the PDCD1 gene in ankylosing spondylitis

Wu, Ye; Chen, Yuting; Sun, Xiaoya; Deng, Yujie; Ni, Man; Pan, Faming

doi:10.1038/s41435-023-00196-w

Cited by 4 publications

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Less research has been done on DNA methylation's role in spondyloarthropathies (SpA) compared to RA (59, 60). Ankylosing spondylitis (AS) patients' peripheral blood has been found to have altered DNA methylation levels (61)(62)(63). In AS patients but not in healthy controls, the inflammatory gene SOCS-1 (suppressor of cytokine signaling 1) is methylated (64).…”

Section: Dna Methylation In Autoimmune Diseasementioning

confidence: 99%

Functional significance of DNA methylation: epigenetic insights into Sjögren’s syndrome

Wang,

Riaz,

Wang

et al. 2024

Front. Immunol.

View full text Add to dashboard Cite

Sjögren’s syndrome (SjS) is a systemic, highly diverse, and chronic autoimmune disease with a significant global prevalence. It is a complex condition that requires careful management and monitoring. Recent research indicates that epigenetic mechanisms contribute to the pathophysiology of SjS by modulating gene expression and genome stability. DNA methylation, a form of epigenetic modification, is the fundamental mechanism that modifies the expression of various genes by modifying the transcriptional availability of regulatory regions within the genome. In general, adding a methyl group to DNA is linked with the inhibition of genes because it changes the chromatin structure. DNA methylation changes the fate of multiple immune cells, such as it leads to the transition of naïve lymphocytes to effector lymphocytes. A lack of central epigenetic enzymes frequently results in abnormal immune activation. Alterations in epigenetic modifications within immune cells or salivary gland epithelial cells are frequently detected during the pathogenesis of SjS, representing a robust association with autoimmune responses. The analysis of genome methylation is a beneficial tool for establishing connections between epigenetic changes within different cell types and their association with SjS. In various studies related to SjS, most differentially methylated regions are in the human leukocyte antigen (HLA) locus. Notably, the demethylation of various sites in the genome is often observed in SjS patients. The most strongly linked differentially methylated regions in SjS patients are found within genes regulated by type I interferon. This demethylation process is partly related to B-cell infiltration and disease progression. In addition, DNA demethylation of the runt-related transcription factor (RUNX1) gene, lymphotoxin-α (LTA), and myxovirus resistance protein A (MxA) is associated with SjS. It may assist the early diagnosis of SjS by serving as a potential biomarker. Therefore, this review offers a detailed insight into the function of DNA methylation in SjS and helps researchers to identify potential biomarkers in diagnosis, prognosis, and therapeutic targets.

show abstract

Section: Dna Methylation In Autoimmune Diseasementioning

confidence: 99%